First-in-Human Study of JNJ-79635322 (JNJ-5322), a Novel Next-Generation Trispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Initial Phase 1 Results


Por: Lee, H, Popat, R, Touzeau, C, Perrot, A, Anguille, S, Oriol, A, Kint, N, Caers, J, Minnema, MC, Kaiser, M, Garfall, A, Matous, J, Sanchez, L, Borogovac, A, Karlin, L, Rosinol, L, Roeloffzen, W, Usmani, S, Varga, C, Pan, D, Ishida, T, Minnick, P, Smit, MD, Daskalakis, N, Prior, T, Krevvata, M, Nguyen, A, Hilder, B, Jonathan, D, Weidman, J, Lee, S, Mateos, MV, Rodriguez-Otero, P, Vega, G and van de Donk, NWCJ

Publicada: 1 sep 2025
Resumen:


Filiaciones:
Lee, H:
 Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA

Popat, R:
 Univ Coll London Hosp NHS Fdn Trust, Natl Inst Hlth Res, Clin Res Facil, London, England

Touzeau, C:
 Ctr Hosp Univ Nantes, Nantes, France

Perrot, A:
 Univ Toulouse, Univ Paul Sabatier, Inst Univ Canc Toulouse Oncopole, Serv Hematol,CHU Toulouse, Toulouse, France

Anguille, S:
 Univ Antwerp, Antwerp Univ Hosp, Div Hematol, Antwerp, Belgium

 Univ Antwerp, Antwerp Univ Hosp, Ctr Cell Therapy & Regenerat Med, Antwerp, Belgium

:
 Hosp Badalona Germans Trias i Pujol, Inst Catala Oncol, Badalona, Spain

 Hosp Germans Trias i Pujol, Inst Josep Carreras, Badalona, Spain

Kint, N:
 Ghent Univ Hosp, Dept Hematol, Ghent, Belgium

Caers, J:
 CHU Liege, Dept Hematol, Liege, Belgium

Minnema, MC:
 Univ Med Ctr Utrecht, Utrecht, Netherlands

Kaiser, M:
 Royal Marsden NHS Trust, London, England

Garfall, A:
 Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA USA

Matous, J:
 Sarah Cannon Res Inst, Colorado Blood Canc Inst, Denver, CO USA

Sanchez, L:
 Icahn Sch Med Mt Sinai, New York, NY USA

Borogovac, A:
 City Hope Natl Med Ctr, Duarte, CA USA

Karlin, L:
 Ctr Hosp Lyon Sud, Serv Hematol Clin, Pierre Benite, France

Rosinol, L:
 Univ Barcelona, Hosp Clin, Dept Hematol, IDIBAPS, Barcelona, Spain

Roeloffzen, W:
 Univ Med Ctr Groningen, Groningen, Netherlands

Usmani, S:
 Mem Sloan Kettering Canc Ctr, New York, NY USA

Varga, C:
 Atrium Hlth, Levine Canc Inst, Dept Hematol, Charlotte, NC USA

Pan, D:
 Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA

Ishida, T:
 Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan

Minnick, P:
 Johnson & Johnson, Spring House, PA USA

Smit, MD:
 Enliven Therapeut, Boulder, CO USA

Daskalakis, N:
 Johnson & Johnson, Spring House, PA USA

Prior, T:
 Johnson & Johnson, Spring House, PA USA

Krevvata, M:
 Johnson & Johnson, Spring House, PA USA

Nguyen, A:
 Johnson & Johnson, Spring House, PA USA

Hilder, B:
 Johnson & Johnson, Spring House, PA USA

Jonathan, D:
 Johnson & Johnson, Spring House, PA USA

Weidman, J:
 Johnson & Johnson, Spring House, PA USA

Lee, S:
 Johnson & Johnson, Spring House, PA USA

Mateos, MV:
 Univ Hosp Salamanca, IBSAL CIC CIBERONC, Salamanca, Spain

Rodriguez-Otero, P:
 Univ Navarra, Clin DISN, CIMA, CIBERONC,IA, Pamplona, Spain

Vega, G:
 Hosp Fdn Jimenez Diaz, Div Hematol, START Madrid FJD, Madrid, Spain

van de Donk, NWCJ:
 Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands
ISSN: 21522650





Clinical Lymphoma Myeloma & Leukemia
Editorial
Cancer Media Group, 3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 25 Número:
Páginas:
WOS Id: 001605583000006

MÉTRICAS